Back
Belite Bio, Inc. Stock Price Chart
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
54
BLTE
Belite Bio, Inc.
Last Price:
$154.94
Seasonality Move:
-4.96%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BLTE is experiencing slight buying pressure.
Belite Bio, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 157.09 | Sell |
| 20-day SMA: | 157.35 | Sell |
| 50-day SMA: | 141.33 | Buy |
| 200-day SMA: | 85.7 | Buy |
| 8-day EMA: | 155.59 | Sell |
| 20-day EMA: | 154.51 | Buy |
| 50-day EMA: | 140.17 | Buy |
| 200-day EMA: | 97.7 | Buy |
Belite Bio, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.76 | Buy |
| Relative Strength Index (14 RSI): | 53.44 | Buy |
| Chaikin Money Flow: | 78889 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (149.13 - 161.05) | Buy |
| Bollinger Bands (100): | (73.53 - 144.93) | Buy |
Belite Bio, Inc. Technical Analysis
| Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | Jan 12 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Belite Bio, Inc. Stock
Is Belite Bio, Inc. Stock a Buy?
-
Belite Bio, Inc. share price is 155.11 while BLTE 8-day simple moving average is 157.09, which is a Sell signal.
-
The stock price of BLTE is 155.11 while Belite Bio, Inc. 20-day SMA is 157.35, which makes it a Sell.
-
Belite Bio, Inc. 50-day simple moving average is 141.33 while BLTE share price is 155.11, making it a Buy technically.
-
BLTE stock price is 155.11 and Belite Bio, Inc. 200-day simple moving average is 85.70, creating a Buy signal.
BLTE Technical Analysis vs Fundamental Analysis
Buy
54
Belite Bio, Inc. (BLTE)
is a Buy
Is Belite Bio, Inc. a Buy or a Sell?
-
Belite Bio, Inc. stock is rated a BuyThe current Belite Bio, Inc. [BLTE] share price is $155.11. The Score for BLTE is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
Belite Bio, Inc. Stock Info
Market Cap:
5.8B
Price in USD:
155.11
Share Volume:
159.5K
Belite Bio, Inc. 52-Week Range
52-Week High:
170.25
52-Week Low:
49.00
Buy
54
Belite Bio, Inc. (BLTE)
is a Buy
Belite Bio, Inc. Share Price Forecast
-
What is the Belite Bio, Inc. stock price today?The Belite Bio, Inc. stock price is 155.11 USD today.
-
Will BLTE stock go up or go down?Belite Bio, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Belite Bio, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Belite Bio, Inc. is not overvalued.
Is Belite Bio, Inc. Stock a Buy?
-
Belite Bio, Inc. share price is 155.11 while BLTE 8-day exponential moving average is 155.59, which is a Sell signal.
-
The stock price of BLTE is 155.11 while Belite Bio, Inc. 20-day EMA is 154.51, which makes it a Buy.
-
Belite Bio, Inc. 50-day exponential moving average is 140.17 while BLTE share price is 155.11, making it a Buy technically.
-
BLTE stock price is 155.11 and Belite Bio, Inc. 200-day simple moving average is 97.70, creating a Buy signal.
Fundamental Analysis of Belite Bio, Inc.
Is Belite Bio, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.29 per share, and an increase next year of $0.33 per share.
Technical Analysis of Belite Bio, Inc.
Should I short Belite Bio, Inc. stock?
-
BLTE Moving Average Covergence Divergence (MACD) indicator is 3.76, suggesting Belite Bio, Inc. is a Buy
-
Belite Bio, Inc. Relative Strength Index (RSI) is 53.44, which suggest Belite Bio, Inc. is overbought
-
The Bollinger Bands (25) for Belite Bio, Inc. is (149.13 - 161.05), which suggest Belite Bio, Inc. is a Buy
-
The Bollinger Bands (100) for Belite Bio, Inc. is (73.53 - 144.93), which suggest Belite Bio, Inc. is a Buy
* Belite Bio, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.